Cargando…

Disposition, metabolism and mass balance of [(14)C]apremilast following oral administration

1. Apremilast is a novel, orally available small molecule that specifically inhibits PDE4and thus modulates multiple pro- and anti-inflammatory mediators, and is currently under clinical development for the treatment of psoriasis and psoriatic arthritis.The pharmacokinetics and disposition of [(14)C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffmann, Matthew, Kumar, Gondi, Schafer, Peter, Cedzik, Dorota, Capone, Lori, Kei-Fong, Lai, Gu, Zheming, Heller, Dennis, Feng, Hao, Surapaneni, Sekhar, Laskin, Oscar, Wu, Anfan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231940/ https://www.ncbi.nlm.nih.gov/pubmed/21859393 http://dx.doi.org/10.3109/00498254.2011.604745

Ejemplares similares

Absorption, metabolism and excretion of [(14)C]pomalidomide in humans following oral administration
por: Hoffmann, Matthew, et al.
Publicado: (2012)

The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers
por: Liu, Yong, et al.
Publicado: (2014)

Pharmacokinetics, metabolism and excretion of [(14)C]-lenalidomide following oral administration in healthy male subjects
por: Chen, Nianhang, et al.
Publicado: (2011)

The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritis
por: Liu, Yong, et al.
Publicado: (2014)

The effects of apremilast on the QTc interval in healthy male volunteers: a formal, thorough QT study
por: Palmisano, Maria, et al.
Publicado: (2016)

In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine
por: Chen, Yong, et al.
Publicado: (2010)

Pediatric psoriasis treated with apremilast
por: Smith, Rebecca L.
Publicado: (2016)

Erythrodermic Psoriasis Treated with Apremilast
por: Arcilla, John, et al.
Publicado: (2016)

Repigmentation of Tenacious Vitiligo on Apremilast
por: Huff, Sara B., et al.
Publicado: (2017)

Apremilast in Refractory Alopecia Areata
por: Estébanez, Andrea, et al.
Publicado: (2019)

Treatment of erythrodermic psoriasis with apremilast
por: Gioe, Olivia A., et al.
Publicado: (2021)

Large-scale Analyses of Disease Biomarkers and Apremilast Pharmacodynamic Effects
por: Medvedeva, Irina V., et al.
Publicado: (2020)

Worsening of Lymphopenia during Apremilast Treatment
por: Kolios, Antonios G.A., et al.
Publicado: (2016)

Apremilast for treatment of recalcitrant aphthous stomatitis
por: Schibler, Fabian, et al.
Publicado: (2017)

Apremilast as an adjuvant therapy for calcinosis cutis
por: Qiblawi, Sultan H., et al.
Publicado: (2019)

Treatment of a perforating dermatosis with apremilast
por: McMichael, Josette, et al.
Publicado: (2021)

Apremilast in the Management of Disseminated Granuloma Annulare
por: Joshi, Tejas P, et al.
Publicado: (2021)

Beneficial Impact of Apremilast on Palmoplantar Keratodermas
por: NAKAJIMA, Kimiko, et al.
Publicado: (2021)

Treatment of pyoderma gangrenosum with apremilast monotherapy
por: Bordeaux, Zachary A., et al.
Publicado: (2022)

Apremilast or Methotrexate: The Arrows in the Quiver for Psoriasis
por: Panda, Gautam, et al.
Publicado: (2023)

Disposition of (14)C and/or (74)As-cacodylic acid in rats after intravenous, intratracheal, or peroral administration
por: Stevens, J. T., et al.
Publicado: (1977)

Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
por: Gooderham, Melinda, et al.
Publicado: (2015)

Clinical potential of apremilast in the treatment of psoriatic arthritis
por: Cauli, Alberto, et al.
Publicado: (2014)

Recurrence of Melanoma after Starting Apremilast for Psoriasis
por: Salopek, Thomas G.
Publicado: (2017)

Successful treatment of refractory folliculitis decalvans with apremilast
por: Fässler, Mirjam, et al.
Publicado: (2020)

Refractory erythema annulare centrifugum treated with apremilast
por: Lee, Michelle S., et al.
Publicado: (2021)

Apremilast induced tinnitus: An unreported side effect
por: Sule, Rajiv Ramesh, et al.
Publicado: (2021)

Apremilast in Paediatric Dermatoses – A Comprehensive Review
por: Patro, Nibedita, et al.
Publicado: (2022)

Crushed apremilast for the treatment of oral lichen planus
por: Kim-Lim, Penelope, et al.
Publicado: (2023)

Apremilast ameliorates acute respiratory distress syndrome by inhibiting neutrophil-induced oxidative stress
por: Tsai, Yung-Fong, et al.
Publicado: (2023)

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
por: Forchhammer, Stephan, et al.
Publicado: (2015)

Crystal structure of an apremilast ethanol hemisolvate hemihydrate solvatomorph
por: Wu, Yun-Deng, et al.
Publicado: (2017)

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2016)

Case Report: Apremilast for Therapy-Resistant Pemphigus Vulgaris
por: Meier, Katharina, et al.
Publicado: (2020)

Apremilast-associated drug reaction with eosinophilia and systemic symptoms
por: Chapman, Stephanie, et al.
Publicado: (2020)

Recurrent generalized pustular psoriasis possibly triggered by apremilast
por: Wang, Wen-Ming, et al.
Publicado: (2020)

Pharmacokinetics and tolerability of apremilast in healthy Korean adult men
por: Huh, Ki Young, et al.
Publicado: (2021)

Apremilast monotherapy for palmoplantar pustulosis: Report of three cases
por: Marovt, Maruška, et al.
Publicado: (2021)

Apremilast as a treatment for morphea: A case series
por: Koschitzky, Merav, et al.
Publicado: (2021)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
por: Gao, Jia C, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0fmlsgp1n41qvmimlfb9lhipus